Dr. V said patients are lined up for 836, not surprising since MSS stage 4 cancers have 0 effective treatment. LD taxol is TME modulator, combo with cetuximab showed high ORR in MSS CRC. Adding 836 to that would raise the ORR even higher,
Market Data 
Markets 
AI
